Sigara Içmenin Aurasız Migren Hastalarında Atak Sıklıgı ve Maluliyet Üzerindeki Etkisi
Öz
Anahtar Kelimeler
References
- 1. World Health Organization (2011). Atlas of headache disorders and resources in the world
- Genevahttps://www.who.int/mental_health/management/wh o_atlas_headache_disorders.pdf?ua=1. Last Updated at: 4.12.2018
- 2. Lipton, R.B., Hamelsky, S.W., Kolodner, K.B., Steiner, T.J., Stewart, W.F. (2000) Migraine, quality of life, and depression. A
- population – based case-control study. Neurology. 12;(55) 5:629-35. PMID: 10980724 3. Smitherman, T.A., Burch, R., Sheik, H., Loder, E. (2013) The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 53(3):427-36. PMID: 234700015
- 4. Stewart, WF, Lipton, R.B., Dowson, A.J., Sawyer, J. (2001) Development and testing of the Migraine Disability Assessment
- (MIDAS) Questionnaire to assess headache-related disability. Neurology. 56 (6 Suppl 1): S20–8. PMID: 11294956
- 5. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict; 86: 1119-27.
- 6. Yaman M., Demirkıran M.K., Oruç S. (2007) Migrende Baş ağrısını Tetikleyici ve Kötüleştirici Faktörler. Düzce Tip Fakültesi Dergisi;3:9-13
Details
Primary Language
Turkish
Subjects
Clinical Sciences
Journal Section
Research Article
Authors
Esra Yalçın
*
This is me
Türkiye
Bektaş Murat Yalçın
*
This is me
Türkiye
Tevfik Fikret Karahan
This is me
Türkiye
Publication Date
July 5, 2022
Submission Date
October 22, 2020
Acceptance Date
-
Published in Issue
Year 2020 Volume: 8 Number: 2